BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,131,000 | -51.9% | 144,476 | -44.1% | 0.16% | -22.2% |
| Q4 2021 | $35,623,000 | +2.5% | 258,497 | +3.3% | 0.20% | +12.8% |
| Q3 2021 | $34,745,000 | +43.0% | 250,126 | -0.0% | 0.18% | +51.3% |
| Q2 2021 | $24,293,000 | +34.9% | 250,238 | -5.0% | 0.12% | +22.7% |
| Q1 2021 | $18,005,000 | +107.4% | 263,420 | +160.0% | 0.10% | +125.6% |
| Q4 2020 | $8,683,000 | +31.2% | 101,307 | -0.5% | 0.04% | +4.9% |
| Q3 2020 | $6,616,000 | -11.6% | 101,771 | -0.6% | 0.04% | -30.5% |
| Q2 2020 | $7,483,000 | +115.3% | 102,352 | +0.2% | 0.06% | +40.5% |
| Q1 2020 | $3,476,000 | +24.6% | 102,159 | +36.9% | 0.04% | +7.7% |
| Q3 2017 | $2,790,000 | +44.6% | 74,637 | -3.3% | 0.04% | +34.5% |
| Q2 2017 | $1,929,000 | – | 77,169 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |